drugset / Trial / NCT02623816

Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

NCT02623816

Phase 4 Completed 64 enrolled MetroHealth Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The overall aim of this study is to assess if patients with persistent gastroesophageal reflux disease (GERD) symptoms receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking omeprazole 30 minutes prior to the first meal of the day.

Timeline

Start
2014-08
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg

Indications